Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer

被引：0
|
作者：
Kapoor, Avnish [1 ]
Yao, Wantong [1 ]
Ying, Haoqiang [1 ]
Hua, Sujun [1 ]
Liewen, Alison [1 ]
Sadanandam, Anguraj [2 ]
Al-Khalil, Ramsey [1 ]
Viale, Andrea [1 ]
Pettazzoni, Piergiorgio [1 ]
Sanchez, Nora [1 ]
Protopopov, Alexei [1 ]
Zhang, Jianhua [1 ]
Heffernan, Timothy [1 ]
Johnson, Randy L. [1 ]
Chin, Lynda [1 ]
Wang, Y. Alan [1 ]
Draetta, Giulio [1 ]
DePinho, Ronald A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Inst Canc Res, Sutton, Surrey, England
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.PANCA2014-A94
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A94
引用
收藏
页数：1
相关论文
共 50 条
  • [31] USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
    Hou, Pingping
    Ma, Xingdi
    Yang, Zecheng
    Zhang, Qiang
    Wu, Chang-Jiun
    Li, Jun
    Tan, Lin
    Yao, Wantong
    Yan, Liang
    Zhou, Xin
    Kimmelman, Alec C.
    Lorenzi, Philip L.
    Zhang, Jianhua
    Jiang, Shan
    Spring, Denise
    Wang, Y. Alan
    DePinho, Ronald A.
    GENES & DEVELOPMENT, 2021, 35 (19-20) : 1327 - 1332
  • [32] YAP in pancreatic cancer: oncogenic role and therapeutic strategy
    Mao, Wenhao
    Mai, Jia
    Peng, Hui
    Wan, Junhu
    Sun, Ting
    THERANOSTICS, 2021, 11 (04): : 1753 - 1762
  • [33] Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer
    Jeong, Woojin
    Kim, Sang-Bae
    Sohn, Bo Hwa
    Park, Yun-Yong
    Park, Eun Sung
    Kim, Sang Cheol
    Kim, Sung Soo
    Johnson, Randy L.
    Birrer, Michael
    Bowtell, David S. L.
    Mills, Gordon B.
    Sood, Anil
    Lee, Ju-Seog
    ANTICANCER RESEARCH, 2014, 34 (02) : 811 - 817
  • [34] Inhibition of zinc finger protein 367 exerts a tumor suppressive role in colorectal cancer by affecting the activation of oncogenic YAP1 signaling
    Lei, Ting
    Gao, Ya
    Duan, Yuhong
    Cui, Chunli
    Zhang, Li
    Si, Mingming
    ENVIRONMENTAL TOXICOLOGY, 2021, 36 (11) : 2278 - 2290
  • [35] Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
    Collins, Meredith A.
    Brisset, Jean-Christophe
    Zhang, Yaqing
    Bednar, Filip
    Pierre, Josette
    Heist, Kevin A.
    Galban, Craig J.
    Galban, Stefanie
    di Magliano, Marina Pasca
    PLOS ONE, 2012, 7 (12):
  • [36] Modeling Oncogenic Kras Inhibition in Murine Pancreatic Cancer
    Collins, M. A.
    Bednar, F.
    Zhang, Y.
    Rakshit, S.
    Flannagan, K. S.
    Adsay, N. Volkan
    di Magliano, M. Pasca
    PANCREAS, 2011, 40 (08) : 1317 - 1317
  • [37] Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
    Dilly, Julien
    Hoffman, Megan T.
    Abbassi, Laleh
    Li, Ziyue
    Paradiso, Francesca
    Parent, Brendan D.
    Hennessey, Connor J.
    Jordan, Alexander C.
    Morgado, Micaela
    Dasgupta, Shatavisha
    Uribe, Giselle A.
    Yang, Annan
    Kapner, Kevin S.
    Hambitzer, Felix P.
    Qiang, Li
    Feng, Hanrong
    Geisberg, Jacob
    Wang, Junning
    Evans, Kyle E.
    Lyu, Hengyu
    Schalck, Aislyn
    Feng, Ningping
    Lopez, Anastasia M.
    Bristow, Christopher A.
    Kim, Michael P.
    Rajapakshe, Kimal I.
    Bahrambeigi, Vahid
    Roth, Jennifer A.
    Garg, Kavita
    Guerrero, Paola A.
    Stanger, Ben Z.
    Cristea, Simona
    Lowe, Scott W.
    Baslan, Timour
    Van Allen, Eliezer M.
    Mancias, Joseph D.
    Chan, Emily
    Anderson, Abraham
    Katlinskaya, Yuliya V.
    Shalek, Alex K.
    Hong, David S.
    Pant, Shubham
    Hallin, Jill
    Anderes, Kenna
    Olson, Peter
    Heffernan, Timothy P.
    Chugh, Seema
    Christensen, James G.
    Maitra, Anirban
    Wolpin, Brian M.
    CANCER DISCOVERY, 2024, 14 (11) : 2135 - 2161
  • [38] ABEMACICLIB IS EFFECTIVE AGAINST PANCREATIC CANCER CELLS AND SYNERGIZES WITH HUR AND YAP1 INHIBITION
    Dhir, Teena
    Schultz, Christopher
    Jain, Aditi
    Yeo, Charles J.
    Golan, Talia
    Brody, Jonathan R.
    GASTROENTEROLOGY, 2019, 156 (06) : S1416 - S1417
  • [39] YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
    Zhou, Qimin
    Bauden, Monika
    Andersson, Roland
    Hu, Dingyuan
    Marko-Varga, Gyorgy
    Xu, Jianfeng
    Sasor, Agata
    Dai, Hua
    Pawlowski, Krzysztof
    Hilmersson, Katarzyna Said
    Chen, Xi
    Ansari, Daniel
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [40] Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
    Dhir, Teena
    Schultz, Christopher W.
    Jain, Aditi
    Brown, Samantha Z.
    Haber, Alex
    Goetz, Austin
    Xi, Chunhua
    Su, Gloria H.
    Xu, Liang
    Posey, James, III
    Jiang, Wei
    Yeo, Charles J.
    Golan, Talia
    Pishvaian, Michael J.
    Brody, Jonathan R.
    MOLECULAR CANCER RESEARCH, 2019, 17 (10) : 2029 - 2041
12345